QTQiuxiang Tan

Qiuxiang Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiuxiang Tan has a total of 60 co-authors. Here are the top co-authors by number of shared publications:

  • Beili Wu

    State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    6 shared publications
  • Qiang Zhao

    State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203

    6 shared publications
  • Cuiying Yi

    State Key laboratory of Drug, Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    3 shared publications
  • Limin Ma

    State Key laboratory of Drug, Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    3 shared publications
  • Mu Wang

    State Key laboratory of Drug, Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    3 shared publications
  • Shuo Han

    CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    3 shared publications

Latest Publications

  • Open Access

    Ligand binding modes of the bitter taste receptor T2R14 and T2R46

    by Qiuxiang Tan, Yu Yu, Xuteng Han, Kezhen Liu, Shuo Han, Mu Wang, Yuan Wei, Yingrong Zhu, Qiuru Chen, Limin Ma, et al.

    Bitter taste receptors (T2Rs) are considered attractive drug targets. However, the ligand recognition and selectivity of these receptors remain elusive, hampering their drug development. Here we present seven structures of human T2R14 and T2R46 in apo or ligand-bound state. Combined with molecular docking and mutagenesis data, the structures reveal an extracellular ligand-binding site in T2R14 for most of its ligands, which is different from the intracellular binding site reported recently. In contrast, T2R46 exhibits a conserved binding pocket that accommodates various ligands with distinct interaction patterns. Furthermore, the second extracellular loop in T2R14 and T2R46 acts as a tethered agonist to potentially facilitate agonist response of these two receptors to the weak tastant agonists. These findings could accelerate drug discovery targeting T2Rs.


  • Open Access

    Structural basis of allosteric and bitopic ligands binding in sphingosine-1-phosphate receptors 2 and 3

    by Yanhong Wu, Qiuru Chen, Hongyu Wang, Kezhen Liu, Jiaxin Wei, Mu Wang, Kun Chen, Ya Zhu, Shuo Han, Cuiying Yi, et al.

  • Open Access

    Structural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R

    by Beibei Li, Shuo Han, Mu Wang, Yu Yu, Limin Ma, Xiaojing Chu, Qiuxiang Tan, Qiang Zhao, Beili Wu

    Dear Editor,


  • Open Access

    Activation of the human chemokine receptor CX3CR1 regulated by cholesterol

    by Minmin Lu, Wenli Zhao, Shuo Han, Xiaowen Lin, Tingyu Xu, Qiuxiang Tan, Mu Wang, Cuiying Yi, Xiaojing Chu, Weibo Yang, et al.

    As the only member of the CX3C chemokine receptor subfamily, CX3CR1 binds to its sole endogenous ligand CX3CL1, which shows notable potential as a therapeutic target in atherosclerosis, cancer, and neuropathy. However, the drug development of CX3CR1 is hampered partially by the lack of structural information. Here, we present two cryo–electron microscopy structures of CX3CR1-G i1 complexes in ligand-free and CX3CL1-bound states at 2.8- and 3.4-Å resolution, respectively. Together with functional data, the structures reveal the key factors that govern the recognition of CX3CL1 by both CX3CR1 and US28. A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-G i complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules that play essential roles in conformation stabilization and signaling transduction. Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein–coupled receptor) signaling and provide insights into the diversity of G protein coupling.


  • Open Access

    Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors

    by Tingting Tang, Qiuxiang Tan, Shuo Han, Anne Diemar, Kristin Löbner, Hongyu Wang, Corinna Schüß, Victoria Behr, Karin Mörl, Mu Wang, et al.

    In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.


  • Top Cited Papers

    Structural basis of G s and G i recognition by the human glucagon receptor

    by Anna Qiao, Shuo Han, Xinmei Li, Zhixin Li, Peishen Zhao, Antao Dai, Rulve Chang, Linhua Tai, Qiuxiang Tan, Xiaojing Chu, et al.

    Choosing a partner that fits: G protein–coupled receptors (GPCRs) are responsible for transducing diverse signals from outside to inside cells. This process requires specificity both in ligand binding to GPCRs and in coupling between GPCRs and their intracellular partners, G proteins. Qiao et al. determined the structure of the human glucagon receptor (GCGR), a type B GPCR, bound to glucagon and one of two heterotrimeric G proteins, G s or G i1 . GCGR signals mainly through G s , and the structures provide a basis for this specificity. Conformational changes in GCGR, relative to the inactive state, create a binding cavity for the G proteins. The pocket is opened sufficiently to accommodate a bulky binding motif in G s . G i1 can still bind but the pocket does not close around it, so there is a smaller interaction interface. Science , this issue p. 1346